Antibiotic Resistance

What Causes Antibiotic Resistance?

Antibiotic resistance (ABR) occurs when bacteria, or microbials, that used to be mitigated by antibiotics are now able to withstand the effects of antibiotics. Microbes of the bacteria are not only able to live when treated with antibiotics, but can multiply, causing more stress to the host. When antibiotics are used to treat infections, the host can build up a tolerance if undertreated or mistreated. 

Antibiotic resistance poses a serious global health threat as it can lead to the failure of antibiotic treatment, prolonged illnesses, increased healthcare costs, and higher mortality rates. It limits the options for effective treatment of infections and makes it more challenging to control the spread of diseases. Addressing ABR requires a comprehensive approach, including appropriate antibiotic use, improved infection prevention and control measures, the development of new antibiotics, and global collaboration to tackle this issue.

The Connection Between Antibiotics and Antimicrobial Resistance

Since their invention, germs have been evolving to build a tolerance against the antimicrobial drugs. When the same antimicrobial is overused in humans or animals, the parasite, disease, or virus isn’t as strongly affected or killed off due to this built up tolerance. Over time, this results in antimicrobial resistance as germs are not effectively killed when combated with antimicrobials. 

What Causes Antibiotic Resistance?

Antibiotic misuse and overuse are significant contributing factors to the development of antibiotic resistance. When antibiotics are used inappropriately, such as not completing the full course of treatment or using them for viral infections, it provides an opportunity for bacteria to survive and develop resistance. Antibiotic resistance happens in both humans and animals due to the following factors:

• Overprescription and Inappropriate Use 
  Antibiotics are sometimes prescribed when they are not necessary, such as for viral infections like the common cold or flu, which are not affected by antibiotics. Additionally, incorrect dosage or duration of treatment can contribute to ABR. Addressing this problem requires a multifaceted approach, including responsible antibiotic use, improved infection control measures, the development of new antibiotics, and increased awareness and education about the appropriate use of antibiotics.
  
  
• Agricultural Use
  Antibiotics are frequently used in agricultural practices to promote growth and prevent diseases in livestock. The widespread use of antibiotics in this manner can lead to the development of antibiotic-resistant bacteria that can spread to humans through food consumption or direct contact.
  
  
• Poor Infection Control
  Inadequate hygiene practices in healthcare settings, such as improper handwashing or inadequate sterilization of medical equipment, can facilitate the spread of antibiotic-resistant bacteria.
  
  
• Lack of New Antibiotics
  There has been a decline in the development of new antibiotics in recent decades, leading to a limited arsenal of effective drugs to combat resistant bacterial strains. This makes it more difficult to treat infections caused by antibiotic-resistant bacteria.
  
  
• Bacterial Adaptation
  Bacteria are capable of evolving and adapting to survive the effects of antibiotics. When exposed to antibiotics, some bacteria may acquire genetic mutations or share resistance genes with other bacteria through horizontal gene transfer, enabling them to survive and multiply.
  
  
• Global Travel and Trade
  The movement of people, animals, and goods across borders facilitates the spread of antibiotic-resistant bacteria globally. Resistant strains can be carried by individuals or transferred through contaminated food, water, or environmental sources.

These are just some of the contributing factors to ABR. As new diseases form, economies shift, and the environment changes, there are additional issues that will take a global effort to mitigate. 

Antibiotic Resistance and the Future of One Health

With the ability of bacteria to mutate and resist antibiotics, there are even bigger issues at hand. One Health, the concept of the interconnectedness of all humans, animals, and the environment, is greatly impacted by antibiotic resistance. 

Each pillar of One Health is affected by antibiotic resistance:

• Human Health
  Antibiotic resistant infections are harder to treat, which means patients stay sick, even with diseases once treated by chemotherapy, surgery, or organ transplants. This can cause more deaths and reduced life expectancy rates which will impact the overall economy as well.
  
  
• Animal Health
  Antibiotics are commonly used in veterinary medicine to treat and prevent infections in animals. The emergence of antibiotic resistance in animals not only affects their health and welfare but also has implications for human health. Resistant bacteria can spread from animals to humans through direct contact, consumption of contaminated food, or environmental contamination.
  
  
• Environmental Impact
  Antibiotics and antibiotic-resistant bacteria can enter the environment through the discharge of wastewater from healthcare facilities, agriculture, and pharmaceutical manufacturing. These substances can contribute to the selection and spread of antibiotic resistance in environmental microbial communities, potentially impacting both human and animal health.

With the contamination of our waterways, agriculture, and the overall negative impact on our environment, antibiotic resistance affects us all at an ecological level, which in turn affects us on an environmental level, which inherently impacts our economies. 

One Health efforts must be implemented on a global scale, which poses its own wicked problems. Aligning One Health efforts worldwide is very difficult due to differing economies, cultural ideals, and opposing governmental agendas. However, if antibiotic resistance isn’t mitigated, then we will enter a post-antibiotic era, which will be catastrophic to the environment which will, in turn, cause economic ruin.

How Biomeme is Addressing the Threat of Antibiotic Resistance

Biomeme combats antibiotic resistance in many ways, from Host Response research, testing, and technologies, to our One Health efforts and education of the impact of ABR. 

Biomeme advocates for the responsible use of antimicrobials and antibiotics as the first fundamental step that healthcare providers must take when prescribing medications to patients. Of course, this is easier said than done, especially for smaller economies with fewer resources. With our microcellular tests and technologies, we offer rapid results and insights into an infection, determining how to treat it faster, which helps reduce the inappropriate use of antibiotics.

Additionally, the mobility of our diagnostics gives communities the resources they need, even in impoverished or rural areas. This allows practitioners to treat illnesses on a more global scale, which supports One Health efforts and overall global health. 

How Biomeme is Supporting the Future of One Health & Antibiotic Resistance Efforts

Biomeme is at the forefront of combating antibiotic resistance through multifaceted approaches encompassing Host Response research, testing, technological innovations, and robust One Health advocacy and education initiatives. As proponents of responsible antimicrobial usage, we emphasize the pivotal role of healthcare providers in prescribing medications judiciously, particularly in resource-constrained settings. Leveraging our microcellular tests and technologies, we expedite infection diagnosis, thereby curbing inappropriate antibiotic utilization. Our mobile diagnostics extend access to underserved communities, enabling practitioners to address illnesses on a global scale, reinforcing One Health objectives and advancing overall global health outcomes. 

The escalating threat of antibiotic-resistant bacteria underscores the critical importance of One Health principles, which recognize the interconnectedness of human, animal, and environmental health. Antibiotic resistance permeates each pillar of One Health, manifesting in harder-to-treat infections, elevated mortality rates, and adverse economic impacts in human health; jeopardizing animal welfare and facilitating zoonotic transmission in animal health; and perpetuating environmental contamination, thereby posing risks to both human and animal populations. 

The pervasive ecological ramifications of antibiotic resistance necessitate concerted global One Health efforts, albeit challenged by economic disparities, cultural diversity, and conflicting governmental agendas. Failure to address antibiotic resistance imperils the onset of a post-antibiotic era, portending catastrophic environmental degradation and economic collapse.